22.728 articles found

Differential regional expression patterns of α-synuclein, TNF-α, and IL-1β; and variable status of dopaminergic neurotoxicity in mouse brain after Paraquat treatment.

Mitra S, Chakrabarti N, Bhattacharyya A.

J Neuroinflammation · 2011-11-24

DOI: 10.1186/1742-2094-8-163PMID: 22112368

Pathophysiology of freezing of gait and some possible treatments for it.

Sarbaz Y, Gharibzadeh S, Towhidkhah F.

Med Hypotheses · 2011-11-23

DOI: 10.1016/j.mehy.2011.10.040PMID: 22115695

α-Synuclein synaptic pathology and its implications in the development of novel therapeutic approaches to cure Parkinson's disease.

Bellucci A, Navarria L, Zaltieri M, Missale C, Spano P.

Brain Res · 2011-11-19

DOI: 10.1016/j.brainres.2011.11.031PMID: 22153624

Atypical antipsychotic drugs in the treatment of Parkinson's disease.

Friedman JH.

J Pharm Pract · 2011-11-17

DOI: 10.1177/0897190011426556PMID: 22095576

SYSTEMS AND METHODS FOR ENHANCING OR OPTIMIZING NEURAL STIMULATION THERAPY FOR TREATING SYMPTOMS OF PARKINSONS DISEASE AND OR OTHER MOVEMENT DISORDERS

GLINER BRADFORD EVAN.

· 2011-11-16

Modulation of habit formation by levodopa in Parkinson's disease.

Marzinzik F, Wotka J, Wahl M, Krugel LK, Kordsachia C, Klostermann F.

PLoS One · 2011-11-16

DOI: 10.1371/journal.pone.0027695PMID: 22110725

Herpes simplex virus type 1-based amplicon vectors for fundamental research in neurosciences and gene therapy of neurological diseases.

Jerusalinsky D, Baez MV, Epstein AL.

J Physiol Paris · 2011-11-15

DOI: 10.1016/j.jphysparis.2011.11.003PMID: 22108428

Task-specific writing tremor: clinical phenotypes, progression, treatment outcomes, and proposed nomenclature.

Ondo WG, Satija P.

Int J Neurosci · 2011-11-15

DOI: 10.3109/00207454.2011.630544PMID: 21985650

Efficient gene therapy for Parkinson's disease using astrocytes as hosts for localized neurotrophic factor delivery.

Drinkut A, Tereshchenko Y, Schulz JB, Bähr M, Kügler S.

Mol Ther · 2011-11-15

DOI: 10.1038/mt.2011.249PMID: 22086235

Neuromuscular electrical stimulation versus traditional therapy in patients with Parkinson's disease and oropharyngeal dysphagia: effects on quality of life.

Heijnen BJ, Speyer R, Baijens LW, Bogaardt HC.

Dysphagia · 2011-11-13

DOI: 10.1007/s00455-011-9371-zPMID: 22081122

Do levodopa treatments modify the morphology of the parkinsonian brain?

Vernon AC, Modo M.

Mov Disord · 2011-11-10

DOI: 10.1002/mds.24018PMID: 22076912

Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.

Cerasa A, Pugliese P, Messina D, Morelli M, Gioia MC, Salsone M, Novellino F, Nicoletti G, Arabia G, Quattrone A.

Mov Disord · 2011-11-10

DOI: 10.1002/mds.24017PMID: 22076870